| Literature DB >> 30487903 |
Lilisbeth Perestelo-Perez1,2, Jorge Barraca3, Wenceslao Peñate4, Amado Rivero-Santana2,5, Yolanda Alvarez-Perez5.
Abstract
Background/Objective: This systematic review aims to evaluate the effect of interventions based on the mindfulness and/or acceptance process on ruminative thoughts, in patients with depression. Method: Electronic searches in Medline, Embase, Cochrane Central, PsycInfo, and Cinahl until December 2016, in addition to hand-searches of relevant studies, identified eleven studies that fulfilling inclusion criteria.Entities:
Keywords: Depression; Meta-analysis; Mindfulness; Rumination; Systematic review
Year: 2017 PMID: 30487903 PMCID: PMC6220915 DOI: 10.1016/j.ijchp.2017.07.004
Source DB: PubMed Journal: Int J Clin Health Psychol ISSN: 1697-2600
Figure 1Flow chart of the selection process.
Studies included.
| Author, year, country | Sample | Mean age % women | Taking ADM | On psychotherapy | Intervention | Comparator | Follow up | Rumination measure |
|---|---|---|---|---|---|---|---|---|
| Patients with remitted MDD with at least 2 MDE ( | 44.1 | 0% | n.r. | MBCT (8 weekly group sessions) | 1) Maintenance medication | - | EQ (Rumination subscale) | |
| Patients with current residual depressive symptoms after at least one MDE ( | 43.9 | 34.6% | 12.3% | MBCT (8 weekly group sessions) | TAU | - | RSS | |
| Remitted patients with ≥3 MDE ( | 46.8 | 0% | n.r. | MBCT (8 weekly group sessions) | TAU | 3 and 9 months | RRQ | |
| Patients with ≥3 MDE and residual symptoms ( | 41.8 | 90% | n.r. | MBCT (8 weekly group sessions) | TAU | - | RRS | |
| Patients with MDD ( | 45.8 | n.r. | n.r. | MBCT (8 weekly group sessions) | Cognitive behavioural therapy | - | RRS | |
| College students with BDI > 14 or MDD ( | 19.2 | 12% | 0% | MBCT (4 weekly individual sessions) | 1) Waiting list | 1 month | RRS | |
| Schoenberg et al. (2014) | Patients with MDD and 1-3 past MDE ( | 49.5 | 70.6% | n.r. | MBCT (8 weekly group sessions) | Waiting list | - | RSS |
| Schuver et al. (2016) USA | Women with a history of depression and current MDD ( | 42.8 | 52.5% | 2.5% | MBY (12 weekly group sessions) | Home walking program+ TAU | 1 month | RSS |
| Remitted patients with ≥3 MDE ( | 46.7 | n.r. | 0% | MBCT (8 weekly group sessions) | Waiting list | - | RRS | |
| Patients with ≥3 MDE ( | 47.5 | 49.3% | n.r. | MBCT (8 weekly group sessions) | TAU | - | RSS | |
| Recurrently depressed patients in partial or full remission ( | 47.4 | 50% | 0% | MBCT (8 weekly group sessions) | Waiting list | - | RRS |
Note. ADM: antidepressant medication; EQ: Experience Questionnaire; MBCT: Mindfulness-Based Cognitive Therapy; MBY: Mindfulness-Based Yoga; MDD: major depressive disorder; MDE: major depressive episode; n.r.: non reported; RSS: Rumination on Sadness Scale; RRQ: Rumination/Reflection Questionnaire; RRS: Ruminative Response Scale; TAU: treatment as usual.
Figure 2Meta-analysis of rumination post-scores, separately by design.
Results of the meta-analyses.
| Q ( | I2 | ||||
|---|---|---|---|---|---|
| 8 (516) | −0.59 (−0.77, −0.41) | 3.07 ( | 0% | ||
| RCT | 6 (448) | −0.60 (−0.79, −0.41) | 2.05 ( | 0% | .76 |
| pRCT | 2 (68) | −0.52 (−1.01, −0.03) | 0.93 ( | 0% | |
| Depressed | 4 (188) | −0.63 (−0.93, −0.34) | 1.11 ( | 0% | .71 |
| Full or partial remission | 4 (328) | −0.56 (−0.79, −0.34) | 1.83 ( | 0% | |
| ≥3 episodes | 5 (326) | −0.54 (−0.76, −0.32) | 2.17 ( | 0% | .48 |
| Other criteria | 4 (200) | −0.67 (−0.97, −0.38) | 1.44 ( | 0% | |
| 3 (113) | −0.02 (−0.39, 0.35) | 0.48 ( | 0% | ||
Note. * p-value for the between-group difference.
CI: confidence interval; k: number of estimations; MBCT: Mindfulness-Based Cognitive Therapy; pRCT: pseudo-randomized controlled trial: TAU: treatment as usual.
| Schoenberg et al. (2014) | Schuver et al. (2016) | Van Aalderen et al. (2011) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Was there a comparison group? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 2. Was the comparison group concurrent? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 3. Were participants enrolled into the groups by the researchers? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 4. Was the study described as an RCT? | Yes | Yes | Yes | No | Yes | Yes | No | Yes | Yes | Yes | Yes |
| 5. Was allocation of treatment concealed? | Yes | Yes | Yes | No | Yes | Yes | No | Unclear | Yes | Yes | Yes |
| 6. Was the method used to assign participants to treatment groups truly random? | Yes | Yes | Yes | No | Yes | Yes | No | Yes | Unclear | Yes | Yes |
| 7. Was the assessment of outcomes conducted blind to treatment allocation? | No | Yes | No | Unclear | Yes | Unclear | No | Yes | Yes | Unclear | Yes |
| 8. Has there been a systematic attempt to identify and measure potential confounders? | Yes | Yes | Yes | No | No | Yes | Yes | No | Yes | Yes | Yes |
| 9. Were possible confounders controlled for appropriately in the analysis? | Yes | Yes | Yes | No | Yes | Yes | Yes | No | Yes | Yes | Yes |
| 10. Was the intervention (and control) delivered as planned? | Yes | Yes | Yes | Yes | Yes | Yes | Unclear | Unclear | Unclear | Unclear | Unclear |
| 11. Was there an investigation of possible contamination? | No | No | No | No | No | No | No | No | No | No | No |
| 12. Was contamination accounted for in the analysis? | No | No | No | No | No | No | No | No | No | No | No |
| 13. Was the sample size adequate for the analysis of the main outcome variables? | Yes | Yes | Yes | No | Yes | Yes | No | Yes | Yes | Yes | Yes |
| 14. Were the eligibility criteria for the study adequately specified? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 15. Were participant characteristics described? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 16. Were all participants who began the study accounted for at the end of the study? | Yes | No | No | No | No | Yes | No | No | Yes | Yes | Yes |
| 17. Were at least 80% of participants who began the study assessed at the end of the study? | Yes | No | No | No | No | Yes | Yes | Yes | Yes | Yes | Yes |
| 18. Did analysis include all participants who entered the study and who provided baseline data? | Yes | No | No | No | No | Yes | No | Yes | No | Yes | No |
| 19. Were the methods of analysis appropriate? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 20. Was the main outcome(s) assessed using an appropriate (a validated) measure? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| 21. Were data collected at the same time for both groups? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
| 22. Was the length of follow-up appropriate? | No | No | Yes | No | No | Yes | No | Yes | No | Yes | No |
| Internal validity | Satisfactory | Satisfactory | Satisfactory | Poor | Satisfactory | Satisfactory | Poor | Satisfactory | Satisfactory | Satisfactory | Satisfactory |
| 23. Was any inappropriate coercion used to encourage attendance or assignment to control/comparison groups? | No | No | No | No | No | No | No | No | No | No | No |
| 24. Were the participants unrepresentative of the populations that would receive these treatments in practice? | No | No | No | No | No | No | No | No | No | No | No |
| 25. Did the intervention group have characteristics that would limit its wider adoption? | No | No | No | No | No | No | No | No | No | No | No |
| External validity | Good | Good | Good | Good | Good | Good | Good | Good | Good | Good | Good |